Indeed, from treatments that were once the stuff of science fiction to everyday products that have quietly transformed public ...

Nearly one in ten adults in Great Britain have either recently used GLP-1 weight loss medications or are seriously ...

Structures change or revert, acronyms multiply and every incoming government promises transformation while discovering that ...

Of all the impacts that Donald Trump has had on America’s relationship with the rest of the world, arguably the most material ...

For much of modern medicine, healthcare systems have been structured around treating disease once it becomes clinically ...

Viridian Therapeutics has announced encouraging topline results from its REVEAL‑1 phase 3 clinical trial evaluating ...

Kenneth Hobby, President of Cure SMA, said: “Nearly ten years ago, the approval of Spinraza marked a turning point in SMA ...

This month’s edition reimagines the NHS dichotomy as a dystopian game of Tetris - we investigate which parties might finally ...

Announcing the approval, UCB said Kygevvi is a 2g/2g powder for oral solution and represents the first therapy available in the European Union beyond supportive care. The company noted that TK2d ...

Cure Parkinson’s has announced the formation of a new evaluation panel to review applications submitted to its recent £2 ...

DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access ...

Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...